Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2017, Article ID 8458492, 9 pages
https://doi.org/10.1155/2017/8458492
Research Article

Prognostic Association of Circulating Neutrophil Count with No-Reflow in Patients with ST-Segment Elevation Myocardial Infarction following Successful Primary Percutaneous Intervention

1Department of Cardiology, Beijing Anzhen Hospital, Capital Medical University, Beijing 100029, China
2Beijing Institute of Heart, Lung and Blood Vessel Diseases, Beijing 100029, China
3Cardiovascular Disease Centre of Xiyuan Hospital, China Academy of Chinese Medical Sciences, Beijing 100091, China
4Graduate School, Beijing University of Chinese Medicine, Beijing 100029, China

Correspondence should be addressed to Shuzheng Lyu; nc.moc.liamdem@gnehzuhs

Received 27 June 2017; Revised 30 September 2017; Accepted 31 October 2017; Published 12 December 2017

Academic Editor: Zhongjie Shi

Copyright © 2017 Jinfan Tian et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. A. Kloner, C. E. Ganote, and R. B. Jennings, “The “no-reflow” phenomenon after temporary coronary occlusion in the dog,” The Journal of Clinical Investigation, vol. 54, no. 6, pp. 1496–1508, 1974. View at Publisher · View at Google Scholar
  2. G. Galasso, S. Schiekofer, C. D'Anna et al., “No-reflow phenomenon: pathophysiology, diagnosis, prevention, and treatment. A review of the current literature and future perspectives,” Angiology, vol. 65, no. 3, pp. 180–189, 2014. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Ndrepepa, K. Tiroch, M. Fusaro et al., “5-year prognostic value of no-reflow phenomenon after percutaneous coronary intervention in patients with acute myocardial infarction,” Journal of the American College of Cardiology, vol. 55, no. 21, pp. 2383–2389, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. A. Durante and P. G. Camici, “Novel insights into an “old” phenomenon: the no reflow,” International Journal of Cardiology, vol. 187, pp. 273–280, 2015. View at Publisher · View at Google Scholar · View at Scopus
  5. W. J. van Gaal and A. P. Banning, “Percutaneous coronary intervention and the no-reflow phenomenon,” Expert Review of Cardiovascular Therapy, vol. 5, no. 4, pp. 715–731, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. B. Chandrasekar, J. B. Smith, and G. L. Freeman, “Ischemia-reperfusion of rat myocardium activates nuclear factor-κB and induces neutrophil infiltration via lipopolysaccharide-induced CXC chemokine,” Circulation, vol. 103, no. 18, pp. 2296–2302, 2001. View at Publisher · View at Google Scholar
  7. L. Ge, X. Zhou, W. J. Ji et al., “Neutrophil extracellular traps in ischemia-reperfusion injury-induced myocardial no-reflow: therapeutic potential of DNase-based reperfusion strategy,” American Journal of Physiology Heart and Circulatory Physiology, vol. 308, no. 5, pp. H500–H509, 2015. View at Publisher · View at Google Scholar · View at Scopus
  8. M. Zeng, H. Yan, Y. Chen et al., “Suppression of NF-κB reduces myocardial no-reflow,” PLoS One, vol. 7, no. 10, article e47306, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. S. A. Briaud, Z. M. Ding, L. H. Michael, M. L. Entman, S. Daniel, and C. M. Ballantyne, “Leukocyte trafficking and myocardial reperfusion injury in ICAM-1/P-selectin-knockout mice,” American Journal of Physiology Heart and Circulatory Physiology, vol. 280, no. 1, pp. H60–H67, 2001. View at Google Scholar
  10. K. R. Martin, D. Ohayon, and V. Witko-Sarsat, “Promoting apoptosis of neutrophils and phagocytosis by macrophages: novel strategies in the resolution of inflammation,” Swiss Medical Weekly, vol. 145, article w14056, 2015. View at Publisher · View at Google Scholar · View at Scopus
  11. D. T. Wong, R. Puri, J. D. Richardson, M. I. Worthley, and S. G. Worthley, “Myocardial “no-reflow” — diagnosis, pathophysiology and treatment,” International Journal of Cardiology, vol. 167, no. 5, pp. 1798–1806, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. L. Ao, N. Zou, J. C. Cleveland Jr., D. A. Fullerton, and X. Meng, “Myocardial TLR4 is a determinant of neutrophil infiltration after global myocardial ischemia: mediating KC and MCP-1 expression induced by extracellular HSC70,” American Journal of Physiology Heart and Circulatory Physiology, vol. 297, no. 1, pp. H21–H28, 2009. View at Publisher · View at Google Scholar · View at Scopus
  13. K. Distelmaier, M. P. Winter, F. Dragschitz et al., “Prognostic value of culprit site neutrophils in acute coronary syndrome,” European Journal of Clinical Investigation, vol. 44, no. 3, pp. 257–265, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. P. G. Steg, S. K. James, D. Atar et al., “ESC guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC),” European Heart Journal, vol. 33, no. 20, pp. 2569–2619, 2012. View at Publisher · View at Google Scholar · View at Scopus
  15. S. Wagdy, M. Sobhy, and M. Loutfi, “Neutrophil/lymphocyte ratio as a predictor of in-hospital major adverse cardiac events, new-onset atrial fibrillation, and no-reflow phenomenon in patients with ST elevation myocardial infarction,” Clinical Medicine Insights: Cardiology, vol. 10, pp. 19–22, 2016. View at Publisher · View at Google Scholar · View at Scopus
  16. S. Turkmen, O. Dogdu, K. Tekin et al., “The relationship between neutrophil/lymphocyte ratio and the TIMI flow grade in patients with STEMI undergoing primary PCI,” European Review for Medical and Pharmacological Sciences, vol. 17, no. 16, pp. 2185–2189, 2013. View at Google Scholar
  17. H. Zhou, X. Y. He, S. W. Zhuang et al., “Clinical and procedural predictors of no-reflow in patients with acute myocardial infarction after primary percutaneous coronary intervention,” World Journal of Emergency Medicine, vol. 5, no. 2, pp. 96–102, 2014. View at Publisher · View at Google Scholar
  18. M. Kosuge, K. Kimura, T. Ishikawa et al., “Relation between white blood cell counts and myocardial reperfusion in patients with recanalized anterior acute myocardial infarction,” Circulation Journal, vol. 68, no. 6, pp. 526–531, 2004. View at Publisher · View at Google Scholar · View at Scopus
  19. T. Takahashi, Y. Hiasa, Y. Ohara et al., “Relation between neutrophil counts on admission, microvascular injury, and left ventricularfunctional recovery in patients with an anterior wall first acute myocardial infarction treated with primary coronary angioplasty,” The American Journal of Cardiology, vol. 100, no. 1, pp. 35–40, 2007. View at Publisher · View at Google Scholar · View at Scopus
  20. Z. Wang, L. Ren, L. Lei, H. Ye, and J. Peng, “The relationship between neutrophil counts on admission and angiographic no-reflow after primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction,” Acta Cardiologica, vol. 71, no. 2, pp. 241–246, 2016. View at Publisher · View at Google Scholar
  21. D. J. Hausenloy and D. M. Yellon, “Targeting myocardial reperfusion injury--the search continues,” The New England Journal of Medicine, vol. 373, no. 11, pp. 1073–1075, 2015. View at Publisher · View at Google Scholar · View at Scopus
  22. P. Libby, “Mechanisms of acute coronary syndromes and their implications for therapy,” The New England Journal of Medicine, vol. 368, no. 21, pp. 2004–2013, 2013. View at Publisher · View at Google Scholar · View at Scopus
  23. J. Li, L. Wu, X. Tian, J. Zhang, and Y. Shi, “Intravascular ultrasound observation of the mechanism of no-reflow phenomenon in acute myocardial infarction,” PLoS One, vol. 10, no. 6, article e119223, 2015. View at Publisher · View at Google Scholar · View at Scopus
  24. L. Nilsson, W. G. Wieringa, G. Pundziute et al., “Neutrophil/lymphocyte ratio is associated with non-calcified plaque burden in patients with coronary artery disease,” PLoS One, vol. 9, no. 9, article e108183, 2014. View at Publisher · View at Google Scholar · View at Scopus
  25. M. Madjid, I. Awan, J. T. Willerson, and S. W. Casscells, “Leukocyte count and coronary heart disease: implications for risk assessment,” Journal of the American College of Cardiology, vol. 44, no. 10, pp. 1945–1956, 2004. View at Publisher · View at Google Scholar · View at Scopus
  26. P. Libby, M. Nahrendorf, and F. K. Swirski, “Leukocytes link local and systemic inflammation in ischemic cardiovascular disease: an expanded “cardiovascular continuum”,” Journal of the American College of Cardiology, vol. 67, no. 9, pp. 1091–1103, 2016. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Rotzius, S. Thams, O. Soehnlein et al., “Distinct infiltration of neutrophils in lesion shoulders in ApoE−/− mice,” The American Journal of Pathology, vol. 177, no. 1, pp. 493–500, 2010. View at Publisher · View at Google Scholar · View at Scopus